Head and neck extranodal non-Hodgkin's lymphomas in Indian patients

Though radiotherapy has traditionally been the treatment of choice for patients with localised extranodal lymphomas of the head and neck areas, its adequacy as the sole modality of treatment has come to be questioned. The disease is shown to relapse in other distant extranodal sites especially the gastrointestinal tract. The addition of systemic chemotherapy has been suggested. Fifty-five patients with localised head and neck extranodal lymphomas were treated at the Tata Memorial Hospital during the period 1976-1982, 35 with radiation therapy alone and 20 with combination therapy. The total survival at 5 years was 65% for patients treated with radiation alone and 85% for those treated with combination therapy. The 5 year disease-free survival dropped to 45% for the former group but was 74% for the latter group. This difference was statistically significant (p < 0.01). The authors infer that localised extranodal lymphomas be regarded as a systemic disease and be treated by a multimodal approach. 30 refs.; 2 figs.; 4 tabs